Prediction of delayed lymphopenia after chemoradiotherapy in non-small cell lung cancer

被引：0
|
作者：
Kang, B. [1 ]
Lee, J. H. [1 ]
Xue, L. [1 ]
Son, J. [1 ]
Wu, H. [1 ]
Kim, H. J. [1 ]
Kang, H. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Radiat Oncol, Seoul, South Korea
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1157
引用
收藏
页码：S961 / S961
页数：1
相关论文
共 50 条
  • [21] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [22] Outcome after Preoperative Chemoradiotherapy for Non-Small Cell Lung Cancer with Chest Wall Invasion
    Koike, Y.
    Aokage, K.
    Tada, M.
    Miyoshi, T.
    Tane, K.
    Samejima, J.
    Tsuboi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S572 - S572
  • [23] Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer
    Edwards, Donna M.
    Sankar, Kamya
    Alseri, Aaren
    Jiang, Ralph
    Schipper, Matthew
    Miller, Sean
    Dess, Kathryn
    Strohbehn, Garth W.
    Moghanaki, Drew
    Ramnath, Nithya
    Green, Michael D.
    Bryant, Alex K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (04): : 963 - 970
  • [24] Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancer
    Murata, Saori
    Horinouchi, Hidehito
    Morishita, Momoko
    Kaku, Sawako
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Yamamoto, Noboru
    Okuma, Kae
    Kusumoto, Masahiko
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1396 - S1396
  • [25] Effect analysis of chemoradiotherapy after operation in patients with stage ⅢA non-small cell lung cancer
    Sheng Chen
    Yu-Ling Cheng
    Shi-Ting Li
    Yao-Jun Ni
    Biao Gu
    Asian Pacific Journal of Tropical Medicine, 2012, (10) : 823 - 827
  • [26] Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
    Liu, FangJie
    Wu, YingJia
    Shao, JianHui
    Qiu, Bo
    Guo, SuPing
    Luo, QiaoTing
    Guo, JinYu
    Wang, DaQuan
    Chu, Chu
    Zhou, Rui
    Chen, NaiBin
    Ai, XinLei
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] A retrospective analysis of lymphopenia rates during and after sequential and concurrent radical chemoradiotherapy for patients with stage III non-small cell lung cancer (NSCLC)
    Westley, R.
    Philipps, L.
    Lock, I.
    Ahmed, M.
    Mcdonald, F.
    LUNG CANCER, 2019, 127 : S80 - S80
  • [28] Impact of Heart and Lung Radiation Dose and Lymphopenia on Non-Small Cell Lung Cancer Outcomes
    Little, J.
    Ahmad, S.
    Skwarski, M.
    Smith, D.
    Taylor, B.
    Vasiliadou, I.
    Vivekanandan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S901 - S902
  • [29] Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
    van Rossum, Peter S. N.
    Juan-Cruz, Celia
    Stam, Barbara
    Rossi, Maddalena M. G.
    Lin, Steven H.
    Abravan, Azadeh
    Belderbos, Jose S. A.
    Sonke, Jan-Jakob
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Prediction of Lymphopenia and Survival with Baseline Absolute Lymphocyte Count and Irradiated Dose to Immune Cells in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Yang, G.
    Yoon, H. I.
    Lee, J. G.
    Kim, J.
    Kim, J.
    Kim, K. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E77 - E78
12345